Does an optimal blood TMAO level rule out high pathway activity?

TMAO formation is a well-established diet–microbiome–host pathway, but a single blood result is not a validated measure of its real-time activity or capacity.

Biological pathway

• Human isotope-challenge studies show that dietary L-carnitine can be converted to labeled TMAO, with production nearly abolished during antibiotic-mediated microbial suppression and returning after microbiota recovery. This strongly supports a required microbial step.
• Mechanistically, gut microbial choline TMA-lyase (CutC/CutD) converts choline to trimethylamine (TMA); distinct microbial carnitine pathways also generate TMA. Absorbed TMA is oxidized principally by hepatic flavin-containing monooxygenase 3 (FMO3) to TMAO.
• Microbial functional composition affects output: higher abundance of microbial gbu genes, particularly gbuB, is associated with greater L-carnitine-induced TMAO production. Choline formulation and microbiome composition also influence response patterns.

Interpreting blood TMAO

• An “optimal” or in-range plasma TMAO concentration does not rule out substantial pathway activity. No validated optimal target, universal clinical cutoff, or negative predictive value exists for using a single result to exclude excessive microbial TMA production or hepatic TMA oxidation.
• Concentration is strongly timing-dependent. In controlled oral-carnitine challenges, plasma TMAO remained near trough for approximately 12 hours, rose after 24 hours, and peaked at 24–48 hours. Thus, a fasting or poorly timed sample can be low despite meaningful post-exposure production.
• Kidney clearance is a major confounder: TMAO rises as eGFR declines, so an elevated result may reflect impaired elimination rather than increased generation; conversely, a low value does not establish low production.

Bottom line

• The proposed microbial conversion of dietary precursors to TMA followed by hepatic FMO3-mediated TMAO formation is strongly supported. However, for this 64-year-old woman—or any individual—a single “optimal” blood TMAO value cannot meaningfully exclude high pathway activity without dietary timing, sampling conditions, microbiome-related variability, and renal function being considered.